smallAccCompHo_0921.xslt
Company Registration No. SC853473 (Scotland)
HAWKHILL THERAPEUTICS LIMITED
Financial Statements
for the Period from 25 June 2025 to 31 December 2025

HAWKHILL THERAPEUTICS LIMITED

Financial Statements for the period ending 31 December 2025

CONTENTS PAGE
Company Information 2
Statement of Financial Position 3
Notes to the Accounts 4
- 1 -

HAWKHILL THERAPEUTICS LIMITED

Financial Statements for the period ending 31 December 2025

Company Information

Company Details
Company Number SC853473
Registered Office LIFE SCIENCES INNOVATION HUB
5 JAMES LINDSAY PLACE
DUNDEE
DD1 5JJ
Directors
Directors who held office during the period were:
MBM SECRETARIAL SERVICES LIMITED   
SPAREY, Timothy Jason, Dr   
WOODLAND, Christopher Andrew, Dr   
SHAH, Sunil Rajen Resigned   30/03/2026
BOULANGER, Antoine   
CANNING, Mary, Dr   
PEIXOTO, Francisca, Dr   
- 2 -

HAWKHILL THERAPEUTICS LIMITED

Financial Statements for the period ending 31 December 2025

Statement of Financial Position

123456789
Notes 2025
£ £
Fixed Assets
Intangible assets 5 1 -
Current Assets
Debtors due 11,053 -
Cash at bank and in hand 101,426 -
112,479 -
Creditors
Amount falling due within one year (609,302) -
Net Current Assets (496,823) -
Total Assets less current liabilities (496,822) -
Net Assets (496,822) -
Capital and Reserves
Called up Share Capital 363 -
Retained earnings at end of year (497,185) -
Shareholder funds (496,822) -
For the year ending 31/12/2025 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The members have agreed to the preparation of abridged accounts for this accounting period in accordance with Section 444(2A).
The Directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities.
Approved by the Board on 17 June 2026
Christopher Andrew Woodland
Company Registration No. SC853473
- 3 -

HAWKHILL THERAPEUTICS LIMITED

Financial Statements for the period ending 31 December 2025

Notes to the Accounts

1. Statutory Information
HAWKHILL THERAPEUTICS LIMITED is a private company, limited by shares, registered in Scotland, registration number SC853473.
2. Accounting Policies
Basis of preparing the Financial Statements
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities.
Presentation Currency
The accounts are presented in £ sterling.
- 4 -

HAWKHILL THERAPEUTICS LIMITED

Financial Statements for the period ending 31 December 2025

Notes to the Accounts

3. Employees
Average number of employees, including directors, during the year was as follows:
2025 9
4. Principal Activity
The principal activity of the company is the development of small molecule therapeutics.
- 5 -

HAWKHILL THERAPEUTICS LIMITED

Financial Statements for the period ending 31 December 2025

Notes to the Accounts

5. Intangible Assets
Other Total
Cost £ £
At 25/06/2025 - -
Additions 1 1
Disposals - -
Revaluations - -
At 31/12/2025 1 1
Amortisation
At 25/06/2025 - -
Charge for the Year - -
On Disposals - -
Other increases/(decreases) - -
At end of period - -
Net book value
At 31/12/2025 1 1
At - -
- 6 -